Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,135 | Dovepress* | 6,416+ | 1,070 | 7,486 | |
| PubMed Central* | 719 | 232 | 951 | ||
| Totals | 7,135 | 1,302 | 8,437 | ||
| *Since 18 October 2018 | |||||
View citations on PubMed Central and Google Scholar